Takeda announces availability of type 2 diabetes drugs in US
The FDA approved medications are indicated as an addition to diet and exercise for the treatment of type 2 diabetes. Takeda Pharmaceuticals USA diabetes and obesity marketing senior
Bristol Myers Squibb (BMS) is set to merge its separate research and development (R&D) departments into a single entity, effective from 1 January 2027.
Patent titled ‘Influenza virus-like particles (VLPs) comprising hemagglutinin produced within a plant’ was originally filed by the biopharmaceutical company on 11 July 2008. Medicago business development vice president